Wird geladen...
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
IMPORTANCE: Cardiovascular adverse events (CVAE) with carfilzomib in patients with multiple myeloma can be potentially life-threatening and remain incompletely characterized. We performed the first systematic review and meta-analysis of carfilzomib-associated CVAE. OBJECTIVE: To determine the incide...
Gespeichert in:
| Veröffentlicht in: | JAMA Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Medical Association
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885859/ https://ncbi.nlm.nih.gov/pubmed/29285538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.4519 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|